General Information of DTT (ID: TT1MG9E)

DTT Name Extracellular signal-regulated kinase 1 (ERK1) DTT Info
Gene Name MAPK3

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Preclinical Drug(s)
Investigative Drug(s)
7 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
BVD-523 DMNB4XK Melanoma 2C30 Phase 2 [1]
ASTX029 DMVZXIA Solid tumour/cancer 2A00-2F9Z Phase 1/2 [2]
HH2710 DM0C5MV Solid tumour/cancer 2A00-2F9Z Phase 1/2 [3]
ASN007 DMYHEUA Solid tumour/cancer 2A00-2F9Z Phase 1 [4]
GDC-0994 DMFC2OY Solid tumour/cancer 2A00-2F9Z Phase 1 [5]
JSI-1187 DMVJWBS Solid tumour/cancer 2A00-2F9Z Phase 1 [6]
VAN-10-4-eluting stent DM3ZW6A Artery stenosis BD52 Phase 1 [7]
------------------------------------------------------------------------------------
⏷ Show the Full List of 7 Clinical Trial Drug(s)
1 Preclinical Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
COR-D DMLXMCB T-cell leukaemia 2A90 Preclinical [8]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
6-[(E)-2-(4-Fluoro-phenyl)-vinyl]-9H-purine DMDNG8F Discovery agent N.A. Investigative [9]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 DOI: 10.1158/1538-7445.AM2015-4693
2 Clinical pipeline report, company report or official report of Astex Pharmaceuticals.
3 Clinical pipeline report, company report or official report of HaiHe Biopharma.
4 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
5 ERK Mutations Confer Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors
6 National Cancer Institute Drug Dictionary (drug name JSI1187).
7 WO patent application no. 2013,1850,32, Nanotherapeutics for drug targeting.
8 Corchorusin-D directed apoptosis of K562 cells occurs through activation of mitochondrial and death receptor pathways and suppression of AKT/PKB pathway. Cell Physiol Biochem. 2012;30(4):915-26.
9 Synthesis and biological testing of purine derivatives as potential ATP-competitive kinase inhibitors. J Med Chem. 2005 Feb 10;48(3):710-22.